The purpose of the study is to investigate safety and tolerability of SNIPR001 in healthy volunteers and to evaluate the effect of SNIPR001 on reducing E. coli colonization in the gut
Under the manufacturing agreement, Lonza will provide drug substance for Asher Bio's cis-targeted IL-2 fusion protein
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms
Industry leaders discusses the need of innovation for the Indian drug industry at BioAsia 2022.
The RTP manufacturing facility will support the company's clinical studies and early commercial launch in North America and Europe
It would be the first protein-based alternative available in Israel
Novavax' vaccine has received authorizations of the vaccine in over 170 countries
Emergency Use Authorisation application request to be submitted following one month required by FDA EUA guidance
Alzheimer's disease is a serious, progressive and devastating disease with few treatment options
Subscribe To Our Newsletter & Stay Updated
